Generex Biotechnology Corporation
OTC: GNBTQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joseph Moscato
- Employees
- 15
- Headquarters
- Miramar, United States
- IPO year
- 1998
- Website
- https://generex.com/index.html
Loading GNBTQ…
Loading profile data…Frequently asked questions about GNBTQ
What does Generex Biotechnology Corporation (GNBTQ) do?
Generex Biotechnology Corporation, founded in 1983 and headquartered in Miramar, Florida, was involved in diverse areas within the biotechnology and medical device industries. Initially, the company concentrated on developing and administering large molecule pharmaceutical formulations to the oral cavity using a specialized hand-held aerosol app...
Where does GNBTQ trade?
Generex Biotechnology Corporation (GNBTQ) trades on the Other OTC.
What sector is GNBTQ in?
Generex Biotechnology Corporation (GNBTQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Generex Biotechnology Corporation?
Joseph Moscato is the chief executive officer of Generex Biotechnology Corporation (GNBTQ).
Where is Generex Biotechnology Corporation headquartered?
Generex Biotechnology Corporation is headquartered in United States.
Does GNBTQ pay a dividend?
Generex Biotechnology Corporation (GNBTQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GNBTQ go public?
Generex Biotechnology Corporation (GNBTQ) completed its initial public offering in 1998.